Dose-response effect of depot leuprolide acetate on serum androgens in hirsute women

Fertility and Sterility

Volumn 65, Issue 5, 1996, Pages 912-915

  Rittmaster, R S ^a   Arab, D M ^a   Lehman, L ^a  

^a Gerard Hall   (Canada)

Author keywords

androgens; estrogen replacement; gonadotropin releasing hormone agonist; Hirsutism; leuprolide acetate; polycystic ovary syndrome

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; CONJUGATED ESTROGEN; ESTRADERM 100; ESTRADIOL; GONADORELIN; LEUPRORELIN; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; HIRSUTISM; HORMONE SUBSTITUTION; HUMAN; HYPERANDROGENISM; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUTEINIZING HORMONE BLOOD LEVEL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TESTOSTERONE BLOOD LEVEL; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0029919153     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(16)58259-4     Document Type: Article

References (23)

1. R.J. Chang L.R. Laufer D.R. Meldrum J. DeFazio J.K.H. Lu W.W. Vale Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist J Clin Endocrinol Metab 56 1983 897 903
2. J.L. Andreyko S.E. Monroe R.B. Jaffe Treatment of hirsutism with a gonadotropin-releasing hormone agonist (nafarelin) J Clin Endocrinol Metab 63 1986 854 859
3. N. Faure A. Lemay Ovarian suppression in polycystic ovarian disease during 6 month administration of a luteinizing hormone-releasing hormone (LH-RH) agonist Clin Endocrinol (Oxf) 27 1987 703 713
4. A.E. Calogero M. Macchi V. Montanini A. Mongioi G. Maugeri E. Vicari Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone J Clin Endocrinol Metab 64 1987 980 985
5. D. de Ziegler K. Steingold M. Cedars J.K.H. Lu D.R. Meldrum H.L. Judd Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian syndrome J Clin Endocrinol Metab 68 1989 1111 1117
6. I.A. Williams R.W. Shaw G. Burford An attempt to alter the pathophysiology of polycystic ovary syndrome using a gonadotrophin hormone releasing hormone agonist—nafarelin Clin Endocrinol (Oxf) 31 1989 345 353
7. E.Y. Adashi Potential utility of gonadotropin-releasing hormone agonists in the management of ovarian hyperandrogenism Fertil Steril 53 1990 765 779
8. R.S. Rittmaster D.L. Thompson Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism J Clin Endocrinol Metab 70 1990 1096 1102
9. M.I. Cedars K.A. Steingold D. de Ziegler P.S. Lapolt R.J. Chang H.L. Judd Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction Fertil Steril 57 1992 495 500
10. R.S. Rittmaster Differential suppression of testosterone and estradiol in hirsute women with the superactive gonadotropin-releasing hormone agonist leuprolide J Clin Endocrinol Metab 67 1988 651 655
11. I. Fogelman Gonadotropin-releasing hormone agonists and the skeleton Fertil Steril 57 1992 715 724
12. R.S. Rittmaster Evaluation and treatment of hirsutism Infertility and Reproductive Medicine Clinics of North America 2 1991 511 529
13. K. Miller-Bass E.Y. Adashi Current status and future prospects of transdermal estrogen replacement therapy Fertil Steril 53 1990 961 974
14. J.S. Cook K.L. Doty P.M. Conn J.R. Hansen Assessment of depot leuprolide acetate dose-adequacy for central precocious puberty J Clin Endocrinol Metab 74 1992 1206 1209
15. K.L. Parker R.G. Baens-Bailon P.A. Lee Depot leuprolide acetate dosage for sexual precocity J Clin Endocrinol Metab 73 1991 50 52
16. R.J. Kiltz J. Rutgers J. Phillips M.L. Murugesapillai O.A. Kletzky Absence of a dose-response effect of leuprolide acetate on leiomyomata uteri size Fertil Steril 61 1994 1021 1026
17. Y. Watanabe G. Nakamura Effects of two different doses of leuprolide acetate depot on uterine cavity area in patients with uterine leiomyomata Fertil Steril 63 1995 487 490
18. E. Carmina A. Janni R.A. Lobo Physiological estrogen replacement may enhance the effectiveness of the gonadotropin-releasing hormone agonists in the treatment of hirsutism J Clin Endocrinol Metab 78 1994 126 130
19. J.S. Heiner G.A. Greendale A.K. Kawakami P.S. LaPolt M. Fisher D. Young Comparison of a GnRH agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism J Clin Endocrinol Metab. 80 1995 3412 3418
20. A. Tiitinen N. Simberg U.-H. Stenman Y. Olavi Estrogen replacement does not potentiate gonadotropin-releasing hormone agonist-induced androgen suppression in treatment of hirsutism J Clin Endocrinol Metab 79 1994 447 451
21. K.E. Elkind-Hirsch C. Anania M. Mack R. Malinak Combination gonadotropin-releasing hormone agonist and oral contraceptive therapy improves treatment of hirsute women with ovarian hyperandrogenism Fertil Steril 63 1995 970 978
22. B.R. Carr N.A. Breslau C. Givens W. Byrd C. Barnett-Hamm P.B. Marshburn Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study J Clin Endocrinol Metab 80 1995 1169 1178
23. D. Ferriman J.D. Gallwey Clinical assessment of body hair growth in women J Clin Endocrinol Metab 21 1961 1440 1447